ClinicalTrials.Veeva

Find clinical trials for Lymphoma in Budapest, Budapest

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

B-Cell Lymphoma
Leukemia
Non-Hodgkin Lymphoma
Lymphoid Leukemia
Diffuse Large B-Cell Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
B-Cell Chronic Lymphocytic Leukemia

Lymphoma trials near Budapest, Budapest, HUN:

A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma

treatment of advanced classical Hodgkin lymphoma(HL)...

Active, not recruiting
Hodgkin Lymphoma
Drug: brentuximab vedotin
Drug: bleomycin

Phase 3

Takeda
Takeda

Budapest, Hungary and 215 other locations

The purpose of this study is to assess the antitumor efficacy of single-agent brentuximab vedotin 1.8 mg/kg administered intravenously (IV) every 3 w...

Active, not recruiting
Lymphoma
Drug: Brentuximab vedotin

Phase 4

Takeda
Takeda

Budapest, Hungary and 39 other locations

purpose of this study is to assess the objective response rate of parsaclisib treatment in participants with relapsed or refractory follicular lymphoma...

Active, not recruiting
Lymphoma
Drug: Parsaclisib

Phase 2

Incyte
Incyte

Budapest, Hungary and 82 other locations

This Phase 3 multinational, randomized, double-blind study is designed to compare the efficacy and safety of the combination of ibrutinib and venetoc...

Active, not recruiting
Mantle-Cell Lymphoma
Drug: Ibrutinib
Drug: Venetoclax

Phase 3

Pharmacyclics
Pharmacyclics

Budapest, Hungary and 119 other locations

The purpose of this study is to evaluate the efficacy of loncastuximab tesirine (ADCT-402) combined with rituximab compared to standard immunochemoth...

Enrolling
Relapsed Diffuse Large B-Cell Lymphoma
Refractory Diffuse Large B-Cell Lymphoma
Drug: Oxaliplatin
Drug: Gemcitabine

Phase 3

ADC Therapeutics

Budapest, Hungary and 140 other locations

The purpose of this study was to evaluate whether copanlisib in combination with rituximab is superior to placebo in combination with rituximab in pr...

Active, not recruiting
Lymphoma,Non-Hodgkin
Drug: Rituximab
Drug: Placebo

Phase 3

Bayer
Bayer

Budapest, Hungary and 188 other locations

plus venetoclax (AV) versus venetoclax plus obinutuzumab (VO) in previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma...

Active, not recruiting
Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Drug: Obinutuzumab
Drug: Venetoclax

Phase 3

AstraZeneca
AstraZeneca

Budapest, Hungary and 40 other locations

Locations recently updated

This trial will compare tisagenlecleucel to standard of care in adult participants with relapsed or refractory (r/r) follicular lymphoma....

Enrolling
Follicular Lymphoma (FL)
Biological: Tisagenlecleucel
Drug: Lenalidomide and rituximab (R2) in 28-day cycles for up to 12 cycles.

Phase 3

Novartis
Novartis

Budapest, Hungary and 22 other locations

A multicenter, open-label Phase 2b study of selinexor (KPT-330) in participants with relapsed/refractory (R/R) diffuse large B-cell lymphoma...

Enrolling
Diffuse Large B-cell Lymphoma
Drug: Selinexor

Phase 2

Karyopharm Therapeutics
Karyopharm Therapeutics

Budapest, Hungary and 175 other locations

Locations recently updated

The purpose of this study is to assess the efficacy and safety of of tafasitamab plus lenalidomide in adults with diffuse large B-cell lymphoma...

Enrolling
Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Drug: Tafasitamab
Drug: Lenalidomide

Phase 3

Incyte
Incyte

Budapest, Hungary and 60 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems